PALMI, CHIARA
 Distribuzione geografica
Continente #
NA - Nord America 4.379
AS - Asia 2.460
EU - Europa 2.198
SA - Sud America 306
AF - Africa 49
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 4
Totale 9.400
Nazione #
US - Stati Uniti d'America 4.270
SG - Singapore 1.054
IT - Italia 544
CN - Cina 480
DE - Germania 328
HK - Hong Kong 327
RU - Federazione Russa 319
BR - Brasile 234
SE - Svezia 214
VN - Vietnam 211
IE - Irlanda 178
UA - Ucraina 123
FR - Francia 109
GB - Regno Unito 104
FI - Finlandia 68
IN - India 68
CA - Canada 65
TR - Turchia 45
BD - Bangladesh 40
AT - Austria 36
NL - Olanda 36
IQ - Iraq 33
ID - Indonesia 30
AR - Argentina 27
KR - Corea 27
MX - Messico 27
ES - Italia 26
PL - Polonia 26
BE - Belgio 24
PK - Pakistan 24
JP - Giappone 19
SA - Arabia Saudita 16
ZA - Sudafrica 15
DK - Danimarca 13
UZ - Uzbekistan 13
CO - Colombia 12
VE - Venezuela 12
PH - Filippine 11
CH - Svizzera 10
JO - Giordania 9
MA - Marocco 8
CL - Cile 7
EC - Ecuador 6
KE - Kenya 6
LB - Libano 6
RO - Romania 6
AE - Emirati Arabi Uniti 5
AL - Albania 5
BG - Bulgaria 5
OM - Oman 5
AU - Australia 4
GR - Grecia 4
IL - Israele 4
KZ - Kazakistan 4
MY - Malesia 4
NP - Nepal 4
PY - Paraguay 4
TH - Thailandia 4
TW - Taiwan 4
CZ - Repubblica Ceca 3
EU - Europa 3
HU - Ungheria 3
PA - Panama 3
PT - Portogallo 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
AO - Angola 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EG - Egitto 2
ET - Etiopia 2
HN - Honduras 2
JM - Giamaica 2
LV - Lettonia 2
NO - Norvegia 2
SR - Suriname 2
TN - Tunisia 2
A1 - Anonimo 1
BB - Barbados 1
BF - Burkina Faso 1
BH - Bahrain 1
BT - Bhutan 1
CM - Camerun 1
CY - Cipro 1
EE - Estonia 1
GE - Georgia 1
GL - Groenlandia 1
GY - Guiana 1
IR - Iran 1
KW - Kuwait 1
LK - Sri Lanka 1
LT - Lituania 1
LU - Lussemburgo 1
LY - Libia 1
MK - Macedonia 1
ML - Mali 1
Totale 9.392
Città #
Singapore 703
Ann Arbor 554
Ashburn 444
Fairfield 327
Hong Kong 319
Woodbridge 288
Chandler 257
Houston 251
Frankfurt am Main 219
San Jose 195
Dublin 173
Wilmington 137
Milan 132
Seattle 129
New York 126
Cambridge 116
Jacksonville 115
Dearborn 89
Los Angeles 81
Santa Clara 81
Beijing 76
Chicago 65
Princeton 62
Ho Chi Minh City 55
Nanjing 52
Hanoi 45
Shanghai 45
Dallas 42
The Dalles 41
Hefei 39
Council Bluffs 36
Lissone 34
São Paulo 34
Vienna 33
Lauterbourg 31
Lawrence 30
Munich 30
Altamura 29
Helsinki 27
Moscow 27
Besana In Brianza 25
Brussels 22
Jakarta 22
Seoul 22
Warsaw 22
Buffalo 21
Nanchang 21
Lachine 18
Rome 17
Orem 16
Denver 15
London 15
Toronto 14
Jinan 13
San Diego 13
Amsterdam 12
Tashkent 12
Turku 12
Boardman 11
Guangzhou 11
Paris 11
Rio de Janeiro 11
Baghdad 10
Montreal 10
Mountain View 10
Nuremberg 10
San Francisco 10
Amman 9
Bologna 9
Chennai 9
Hebei 9
Kunming 9
Phoenix 9
Tianjin 9
Ankara 8
Brooklyn 8
Brugherio 8
Da Nang 8
Mexico City 8
Perugia 8
Poplar 8
Riyadh 8
Sesto San Giovanni 8
Boston 7
Dhaka 7
Haiphong 7
Johannesburg 7
New Delhi 7
Norwalk 7
Querétaro 7
Zhengzhou 7
Atlanta 6
Belo Horizonte 6
Desio 6
Dong Ket 6
Gap 6
Istanbul 6
Kurume 6
Lappeenranta 6
Manchester 6
Totale 6.220
Nome #
Pro-inflammatory cytokines favor the emergence of ETV6-RUNX1-positive pre-leukemic cells in a model of mesenchymal niche 467
IKZF1 plus defines a new minimal residual disease-dependent very-poor prognostic profile in pediatric b-cell precursor acute lymphoblastic leukemia 429
Activin A contributes to the definition of a pro-oncogenic bone marrow microenvironment in t(12;21) preleukemia 360
The histone deacetylase inhibitor givinostat (ITF2357) exhibits potent anti-tumor activity against CRLF2-rearranged BCP-ALL 359
The bone marrow niche in b-cell acute lymphoblastic leukemia: The role of microenvironment from pre-leukemia to overt leukemia 317
Cytoskeletal Regulatory Gene Expression and Migratory Properties of B Cell Progenitors are Affected by the ETV6-RUNX1 Rearrangement 316
Targeting of hyperactivated mTOR signaling in high-risk acute lymphoblastic leukemia in a pre-clinical model 306
Suppressors and activators of JAK-STAT signaling at diagnosis and relapse of acute lymphoblastic leukemia in Down syndrome 305
Prognostic value of rare IKZF1 deletion in childhood B-cell precursor acute lymphoblastic leukemia: An international collaborative study 302
Poor prognosis for P2RY8-CRLF2 fusion but not for CRLF2 over-expression in children with intermediate risk B-cell precursor acute lymphoblastic leukemia 301
CRLF2 over-expression is a poor prognostic marker in children with high risk T-cell acute lymphoblastic leukemia 296
SRC/ABL inhibition disrupts CRLF2-driven signaling to induce cell death in B-cell acute lymphoblastic leukemia 296
High-throughput screening as a drug repurposing strategy for poor outcome subgroups of pediatric B-cell precursor Acute Lymphoblastic Leukemia 295
Recurrent genetic fusions redefine MLL germ line acute lymphoblastic leukemia in infants 294
Efficient detection of leukemia-related fusion transcripts by multiplex PCR applied on a microelectronic platform 288
Genetic evidence for lineage-related and differentiation stage-related contribution of somatic PTPN11 mutations to leukemogenesis in childhood acute leukemia 288
PAX5/TEL acts as a transcriptional repressor causing down-modulation of CD19, enhances migration to CXCL12, and confers survival advantage in pre-BI cells 286
PAX5 fusion genes are frequent in poor risk childhood acute lymphoblastic leukaemia and can be targeted with BIBF1120 275
PAX5/ETV6 alters the gene expression profile of precursor B cells with opposite dominant effect on endogenous PAX5 265
Fine Tuning of Surface CRLF2 Expression and Its Associated Signalling Profile in Childhood B Cell Precursor Acute Lymphoblastic Leukemia 260
Phosphoproteomic analysis reveals hyperactivation of mTOR/STAT3 and LCK/Calcineurin axes in pediatric early T-cell precursor ALL 260
What is the relevance of Ikaros gene deletions as prognostic marker in pediatric Philadelphia negative B-cell precursor acute lymphoblastic leukemia? 253
IKZF1 Deletions with COBL Breakpoints Are Not Driven by RAG-Mediated Recombination Events in Acute Lymphoblastic Leukemia 252
Impact of IKZF1 deletions on IKZF1 expression and outcome in Philadelphia chromosome negative childhood BCP-ALL. Reply to "incidence and biological significance of IKZF1/Ikaros gene deletions in pediatric Philadelphia chromosome negative and Philadelphia chromosome positive B-cell precursor acute lymphoblastic leukemia". 246
Fine tuning of surface CRLF2 expression and its associated signaling profile in childhood B-cell precursor acute lymphoblastic leukemia 243
Synergistic drug interactions of the histone deacetylase inhibitor givinostat (ITF2357) in CRLF2-rearranged pediatric B-cell precursor acute lymphoblastic leukemia identified by high-throughput drug screening 237
PAX5 Fusion Genes Activate The STAT5 Signaling Pathway Through Lck Over-Expression 230
A Childhood Leukaemia Cluster in Milan: Possible Role of Pandemic AH1N1 Swine Flu Virus 218
TEL/ARG induces cytoskeletal abnormalities in 293T cells 217
Poor Prognosis for IKZF1 Intra-Gene Deletions in Pediatric Ph– B-Cell Precursor Acute Lymphoblastic Leukemia 204
The TEL-AML1 leukemia fusion gene dysregulates the TGF-beta pathway in early B lineage progenitor cells 201
Treatment outcome of CRLF2 -rearranged childhood acute lymphoblastic leukaemia: A comparative analysis of the AIEOP-BFM and UK NCRI-CCLG study groups 194
Gain-of-function mutations in interleukin-7 receptor-{alpha} (IL7R) in childhood acute lymphoblastic leukemias 182
Inhibition of inflammatory signaling in Pax5 mutant cells mitigates B-cell leukemogenesis 161
The recombinome of IKZF1 deletions in B-cell precursor ALL 160
Totale 9.563
Categoria #
all - tutte 29.645
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.645


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021159 0 0 0 0 0 0 0 0 0 58 55 46
2021/2022505 35 58 63 33 45 35 16 35 15 41 40 89
2022/2023992 100 330 88 90 59 133 28 52 63 16 26 7
2023/2024693 30 16 31 48 89 197 128 35 35 15 10 59
2024/20251.395 58 136 87 54 145 44 81 42 156 232 138 222
2025/20263.238 396 143 230 462 546 200 503 162 306 290 0 0
Totale 9.563